Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

GB Frisoni, M Boccardi, F Barkhof, K Blennow… - The Lancet …, 2017 - thelancet.com
The diagnosis of Alzheimer's disease can be improved by the use of biological measures.
Biomarkers of functional impairment, neuronal loss, and protein deposition that can be …

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

R Boellaard, R Delgado-Bolton, WJG Oyen… - European journal of …, 2015 - Springer
The purpose of these guidelines is to assist physicians in recommending, performing,
interpreting and reporting the results of FDG PET/CT for oncological imaging of adult …

Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19

JA Hosp, A Dressing, G Blazhenets, T Bormann, A Rau… - Brain, 2021 - academic.oup.com
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
neurological symptoms increasingly moved into the focus of interest. In this prospective …

Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

X Xiang, K Wind, T Wiedemann, T Blume… - Science translational …, 2021 - science.org
2-Deoxy-2-[18F] fluoro-d-glucose positron emission tomography (FDG-PET) is widely used
to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is …

EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3

E Guedj, A Varrone, R Boellaard, NL Albert… - European journal of …, 2022 - Springer
The present procedural guidelines summarize the current views of the EANM Neuro-
Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version …

I Law, NL Albert, J Arbizu, R Boellaard… - European journal of …, 2019 - Springer
These joint practice guidelines, or procedure standards, were developed collaboratively by
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …

Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia

C Gasca-Salas, B Fernández-Rodríguez… - Nature …, 2021 - nature.com
MR-guided focused ultrasound (MRgFUS), in combination with intravenous microbubble
administration, has been applied for focal temporary BBB opening in patients with …

Positron emission tomography (PET) in oncology

A Gallamini, C Zwarthoed, A Borra - Cancers, 2014 - mdpi.com
Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …

Brain fluorodeoxyglucose (FDG) PET in dementia

T Kato, Y Inui, A Nakamura, K Ito - Ageing research reviews, 2016 - Elsevier
The purpose of this article is to present a selective and concise summary of
fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG …

18F-FDG PET in parkinsonism: differential diagnosis and evaluation of cognitive impairment

PT Meyer, L Frings, G Rücker… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Accurate differential diagnosis of parkinsonism is of paramount therapeutic and prognostic
importance. In addition, with the development of invasive therapies and novel disease …